Funding collaborations and discovery in treating brain cancers

Incorporating biomarkers into clinical trial design

The evolution of imaging techniques for multiple myeloma

Diagnosis and management of smouldering myeloma

Editor's Choice for April 2018

Phase I taselisib results and a cell-free DNA assay

Impact of microbiome on head and neck cancers

First-in-human trial results of RET targeted BLU-667

Treating RET alterations with novel therapy BLU-667

Tandem duplications in triple negative breast cancer

Analysis tools for NCI genomic databases

Results from GOBACK: Non-chromosomal birth defects linked with cancer